G&E Herbal Biotechnology Co., Ltd. engages in manufacturing and wholesale of western and chinese medicine, cosmetics, intellectual property rights, biotechnology services, medical device, and other unclassified food products in Taiwan. It offers HepaGent capsules, a liver protective agent; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.
Frequently asked questions
What sector does G&E Herbal Biotechnology Co., Ltd. (4911) operate in?
G&E Herbal Biotechnology Co., Ltd. belongs to the Other sector and operates in the Biotechnology industry.
What is G&E Herbal Biotechnology Co., Ltd. (4911) current stock price?
As of the latest data, G&E Herbal Biotechnology Co., Ltd. stock price is NT$28.35, with a previous close of NT$28.35.
What is G&E Herbal Biotechnology Co., Ltd. (4911) current market capitalization?
G&E Herbal Biotechnology Co., Ltd. market cap is approximately 1.95 billion.
What is G&E Herbal Biotechnology Co., Ltd. (4911) Earnings Per Share (EPS)?
The trailing EPS is NT$1.70.
What is G&E Herbal Biotechnology Co., Ltd. (4911) Price-to-Earnings (P/E) ratio?
G&E Herbal Biotechnology Co., Ltd. current P/E ratio is 16.68.
Does G&E Herbal Biotechnology Co., Ltd. (4911) pay dividends?
Yes. G&E Herbal Biotechnology Co., Ltd. pays annual dividends with an annualized yield of 4.11% and an estimated annual payout of NT$1.17 per share.
When is the next ex-dividend date for G&E Herbal Biotechnology Co., Ltd. (4911)?
The next ex-dividend date is scheduled for July 28, 2027.
What is G&E Herbal Biotechnology Co., Ltd. (4911) beta (volatility) score?
G&E Herbal Biotechnology Co., Ltd. has a beta of -0.728, indicating lower volatility than the overall market.